Truveta brand logo mark in teal on a black background, featuring stacked chevron shapes forming the Truveta symbol.

Research

Featured research

Research graphic highlighting increased measles immunity testing during periods of measles outbreak activity.

Measles outbreaks linked to increases in immunity testing among adults over 50

Truveta Research found measles titer testing among adults over 50 increased during the 2019 and 2025 outbreaks, with a sharp rise in Texas in 2025.

Truveta graphic promoting research on e-bike and e-scooter injuries, featuring the headline "E-bike and e-scooter injuries rising rapidly" with a subtitle highlighting increasing emergency department visits among children and adolescents over a background line chart of injury trends.

Emergency department visits related to e-bike and e-scooter injuries are rising rapidly among children and adolescents

Truveta Research finds e-bike and e-scooter injury ED visits rose 7.5-fold among children, with head and neck injuries most common.

Truveta graphic highlighting a JMCP study of real-world switching from Humira (adalimumab) to biosimilars in the United States, with a line chart showing increased biosimilar adoption after formulary changes.

Real-world study finds 1 in 7 patients returned to Humira after switching to an adalimumab biosimilar

A real-world study found 16% of patients switched back to Humira after starting an adalimumab biosimilar, highlighting transition challenges.

Research graphic highlighting rising progesterone-containing hormone replacement therapy use among women from 2018 to 2026.

Progesterone-containing hormone replacement therapy use is rising

Progesterone-containing hormone replacement therapy use is rising. Truveta Research found prescribing increased more than fourfold between 2018 and 2026.

Featured research topics

GLP-1

Oncology

Flu/RSV

Measles

Cardiovascular